Diabetes Mellitus, Noninsulin Dependent Completed Phase 2 Trials for Sitagliptin (DB01261)

Back to Diabetes Mellitus, Noninsulin Dependent

Also known as: Noninsulin-dependent Diabetes Mellitus / Non-Insulin Dependent Diabetes Mellitus / Diabetes Mellitus, Noninsulin-Dependent / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus, Non-Insulin-Dependent / Diabetes mellitus non-insulin-dependent / NIDDM / Diabetes mellitus type 2 (disorder) / Type II diabetes mellitus / Type 2 diabetes mellitus / Diabetes Mellitus, Type 2 / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0043945 (Diabetes Mellitus, Noninsulin Dependent)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00642278
An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 DiabetesTreatment
NCT00758069
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)Treatment